Model | Variables | EORTC/NCIC & LN-Pilot (N = 177) | Nordic study (N = 105) | ||||||
---|---|---|---|---|---|---|---|---|---|
Modality | HR | z-value | Pr( >|z|) | Modality | HR | z-value | Pr( >|z|) | ||
Age acceleration [years] | |||||||||
Treatment (TRT) | TMZ + RT | 1.34862 | 1.31435 | 0.18873 | TMZ | 1.06845 | 0.23966 | 0.81059 | |
MGMT | MGMTmeth | 0.77273 | − 1.10615 | 0.26866 | MGMTmeth | 1.13894 | 0.50912 | 0.61067 | |
Age Acceleration | 0.99124 | − 2.46259 | 0.01379 | 0.98549 | − 3.15493 | 0.00161 | |||
TRT x MGMT | TMZ + RT x MGMTmeth | 0.27215 | − 3.94628 | 0.00008 | TMZ x MGMTmeth | 0.47267 | − 1.66716 | 0.09548 | |
GBM classification | |||||||||
Treatment (TRT) | TMZ + RT | 1.19859 | 0.80597 | 0.42026 | TMZ | 1.12226 | 0.41692 | 0.67674 | |
MGMT | MGMTmeth | 0.70503 | − 1.52048 | 0.12839 | MGMTmeth | 1.05817 | 0.22379 | 0.82292 | |
GBM classification | GBM_RTK_I | 1.54086 | 1.91764 | 0.05516 | GBM_RTK_I | 1.12308 | 0.41675 | 0.67686 | |
GBM_RTK_II | 0.91674 | − 0.48386 | 0.62848 | GBM_RTK_II | 0.52912 | − 2.63579 | 0.00839 | ||
TRT x MGMT | TMZ + RT x MGMTmeth | 0.31994 | − 3.55697 | 0.00038 | TMZ x MGMTmeth | 0.53507 | − 1.39736 | 0.16230 | |
Global HME | |||||||||
Treatment (TRT) | TMZ + RT | 1.12690 | 0.55400 | 0.57958 | TMZ | 1.08996 | 0.30807 | 0.75803 | |
MGMT | MGMTmeth | 0.69179 | − 1.61442 | 0.10644 | MGMTmeth | 0.89983 | − 0.42203 | 0.67300 | |
HME | 3.18126 | 0.49623 | 0.61973 | 164.80788 | 1.64897 | 0.09915 | |||
TMZ + RT x MGMTmeth | 0.34584 | − 3.38245 | 0.00072 | TMZ x MGMTmeth | 0.54313 | − 1.36378 | 0.17264 | ||
HME promoter CpG | |||||||||
Treatment (TRT) | TMZ + RT | 1.15106 | 0.65024 | 0.51554 | TMZ | 1.17499 | 0.58063 | 0.56149 | |
MGMT | Methylated | 0.73235 | − 1.33193 | 0.18288 | MGMTmeth | 0.95937 | − 0.16478 | 0.86912 | |
HME prom CpG | 0.04405 | − 1.14097 | 0.25388 | 0.16488 | − 0.58312 | 0.55982 | |||
TRT x MGMT | TMZ + RT x MGMTmeth | 0.33173 | − 3.48833 | 0.00049 | TMZ x MGMTmeth | 0.53779 | − 1.39207 | 0.16390 |